Paternal gut microbiota and the microbiome−germline axis as a target for prevention and treatment of epigenopathy in the next generation
Microbiology Australia · 12.06.2026 · 47 (2) · 122-127
DOI: 10.1071/ma26126 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Australia, online erschienen am 12.06.2026. Verfasst von Bethany A. Masson und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bethlehem Griffiths Research Foundation, National Health and Medical Research (NHMRC) Ideas Grant, European Union Joint Programme - Neurodegenerative Disease Research.
Abstract (Originalsprache)
The paternal pre-conception environment has been demonstrated in preclinical models to alter the sperm epigenome and offspring phenotypes. Recent studies have reported that modulating the paternal gut microbiota through non-absorbable antibiotics altered offspring body weight, survival, brain transcriptomics and behaviour. Other paternal environmental factors including diet composition, stress and pollutant exposure have also been shown to alter the paternal gut microbiome. This review discusses current evidence on the role of the paternal gut microbiome in epigenetic inheritance and explores its potential as a target to prevent alterations in the sperm epigenome and subsequent detrimental effects on offspring outcomes. This nascent research field (at the nexus of microbiology, epigenetics and neuroscience) will facilitate the prevention and treatment of the growing challenge of ‘intergenerational epigenopathy’ in a rapidly changing world.
Förderung
- Bethlehem Griffiths Research Foundation
- National Health and Medical Research (NHMRC) Ideas Grant
- European Union Joint Programme - Neurodegenerative Disease Research
- ERA-NET NEURON
- Flicker of Hope Foundation
- DHB Foundation
- Margaret Friend Trust
Zitieren
APA
Masson, B. A., Gubert, C., & Hannan, A. J. (2026). Paternal gut microbiota and the microbiome−germline axis as a target for prevention and treatment of epigenopathy in the next generation. Microbiology Australia, 47(2), 122-127. https://doi.org/10.1071/ma26126
Vancouver
Masson BA, Gubert C, Hannan AJ. Paternal gut microbiota and the microbiome−germline axis as a target for prevention and treatment of epigenopathy in the next generation. Microbiology Australia. 2026;47(2):122-127. doi:10.1071/ma26126
BibTeX
@article{Masson2026,
author = {Masson, Bethany A. and Gubert, Carolina and Hannan, Anthony J.},
title = {Paternal gut microbiota and the microbiome−germline axis as a target for prevention and treatment of epigenopathy in the next generation},
journal = {Microbiology Australia},
year = {2026},
volume = {47},
number = {2},
pages = {122--127},
doi = {10.1071/ma26126}
}
EUVIMED